China Releases More Health-Reform Guidelines, But Drug System Delayed
This article was originally published in PharmAsia News
Executive Summary
China's State Council issued additional guidelines of its long-delayed health care reform plan, including a delay in the release of a basic-drugs catalogue until the end of the year. The catalogue is part of a system for pharmaceuticals, also delayed until the end of the year, intended to be implemented in 30 percent of the nation's community clinics and county-level clinics. It already had been disclosed the catalogue drugs would be produced and distributed under government control. The drugs would be covered by medical insurance, requiring another special administration to be established. (Click here for more